Stay Informed on Corporate Sustainability

Author: ALJAZEERA

Eli Lilly becomes the first drugmaker worth $1 trillion as surging demand for obesity drugs fuels record revenue, rapid stock gains, and industry-leading growth driven by Mounjaro, Zepbound, and upcoming GLP-1 innovations.

Author: The Irish Times

Irish goods exports surged 27.8% in September, driven by pharmaceutical growth and soaring US demand, reinforcing Ireland’s strong trade surplus, export resilience, and rising dependence on chemicals and medical products.

Author: Archie Villaflores

Investment, research focus, and competition are shifting across pharma as companies refine strategies that respond to scientific progress and market pressure. This edition brings those movements into clearer view, guided by one idea: leadership that adapts with purpose. The opening feature, Women in Pharma Awards 2026 opens entries to recognise industry leaders, points to how talent development and leadership visibility influence long-term resilience. Recognition programmes signal that organisations are reassessing how capability, diversity, and accountability shape performance. Keenova completes spinout of Par Health and rebrands from Mallinckrodt adds a view of restructuring that reflects broader trends in portfolio management and capital discipline. Businesses are seeking sharper clinical focus and operational clarity, responding to regulatory scrutiny and investor expectation. Novo Nordisk India launches Poviztra with Emcure Pharma shows how established players continue to strengthen therapeutic pipelines through targeted partnerships that expand reach and delivery capacity. These stories mark a period defined by strategic recalibration, closer collaboration, and an appetite for models that support sustainable growth. See how each development contributes to a sector moving with intent, supported by innovation and steady investment in capability.

Author: Archie Villaflores

Entries are now open for the Women in Pharma Awards 2026, honouring outstanding women driving innovation, excellence, and leadership across Ireland’s pharmaceutical landscape.

Author: DealStreetAsia

Rome-based Angelini Ventures has opened its first Asia office in Singapore to support biotech and healthtech innovation. The expansion will strengthen collaboration with local startups and enhance investment opportunities in pharmaceutical and digital health ventures.

Author: Irish Sun

India-based Novo Nordisk has partnered with Emcure Pharma to launch Poviztra, a semaglutide injection for weight management. The collaboration expands distribution across India, strengthening access to innovative pharmaceutical treatments for obesity.

Author: PM LiVE

Smurfit Westrock has launched a €40 million clinical and adherence packaging facility at Dublin Airport. The site will support clinical trials and regulated pharmaceutical packaging for European markets, backed by a 170-strong specialised workforce.

Author: Investing.com

Geode Capital Management discloses a 2.24% stake in Ireland-based Avadel Pharmaceuticals, a company specialising in central nervous system drugs. The regulatory filing highlights increased institutional investment in the Irish pharma sector.

Author: pharmaphorum

Ireland-based specialty pharma company Keenova emerges from Mallinckrodt-Endo restructuring with a focus on branded medicines and a workforce of 1,600. The spinout sets the stage for a planned NYSE listing in 2026 and continued pipeline expansion.

Author: Jed Nykolle Harme

The pharma and life sciences sector continues to advance through operational performance, scientific innovation, and recognition of industry expertise. Organisations are navigating complex markets while driving breakthroughs that impact patients, research, and global healthcare. Strong performance demonstrates resilience and strategic focus. Teva’s Irish arm posts rising profits despite lower revenues highlights the ability of companies to optimise operations, maintain profitability, and invest in ongoing growth even amid challenging market conditions. Scientific innovation is shaping the sector’s trajectory. How SGS is advancing scientific excellence showcases the vital role of rigorous testing, analytical capabilities, and adaptive research strategies in supporting the biopharma landscape and meeting evolving industry standards. Meanwhile, Nuala Calnan to bring expertise to judging panel for the Pharma Industry Awards 2025, highlighting best-in-class practices and bringing more than 2 decades of leadership and expertise in the medtech and biopharmaceutical sectors. These developments reflect a sector where performance, scientific advancement, and leadership converge to drive innovation, operational excellence, and sustainable impact. Explore the full stories and stay informed on the breakthroughs shaping modern pharma and life sciences.